arrow_back Civic Audit
Share share

Request for Documents on Medicare Drug Price Negotiations

This document is a formal request from the House of Representatives to the Secretary of Health and Human Services for documents related to the negotiation of prescription drug prices under the Medicare program. This aims to increase transparency in drug pricing, which could indirectly affect the availability and costs of medications for citizens using this program.
Key points
The House of Representatives demands all documents from the Secretary of Health and Human Services related to Medicare drug price negotiations.
Requested documents include communications on the impact of excise taxes on drug manufacturers and potential loss of future drug development.
The goal is to obtain information on internal and external White House discussions regarding drug pricing and its consequences.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HRES_1284
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
Process start date: 2022-07-26
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1284.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-26.

What are the main provisions?

Key points include:

  • The House of Representatives demands all documents from the Secretary of Health and Human Services related to Medicare drug price negotiations.
  • Requested documents include communications on the impact of excise taxes on drug manufacturers and potential loss of future drug development.
  • The goal is to obtain information on internal and external White House discussions regarding drug pricing and its consequences.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McMorris Rodgers, Cathy [R-WA-5].

What is the latest detailed status?

The latest detailed status is: Placed on the House Calendar, Calendar No. 140.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health